- Home
- CNTA vs NAVN Comparison
CNTA vs NAVN Comparison
Compare CNTA & NAVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | NAVN |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.7B |
| IPO Year | 2021 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CNTA | NAVN |
|---|---|---|
| Price | $25.65 | $13.56 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $38.00 | $25.50 |
| AVG Volume (30 Days) | 1.6M | ★ 1.9M |
| Earning Date | 11-05-2025 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $15,000,000.00 | ★ $656,339,000.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $22.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 118.88 | 63.16 |
| 52 Week Low | $9.60 | $11.76 |
| 52 Week High | $30.58 | $22.75 |
Technical Indicators
Market Signals| Indicator | CNTA | NAVN |
|---|---|---|
| Relative Strength Index (RSI) | 60.26 | 36.89 |
| Support Level | $21.50 | $13.81 |
| Resistance Level | $26.63 | $15.28 |
| Average True Range (ATR) | 1.13 | 0.98 |
| MACD | 0.52 | -0.29 |
| Stochastic Oscillator | 81.48 | 2.29 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About NAVN Navan Inc.
Navan Inc is an end-to-end, AI-powered software platform built to simplify the world-wide business T&E experience, benefiting users, customers, and suppliers. Its leveraged technology to reimagine business travel. The company deliver delightful, personalized experiences for users, efficiency and control for customers, and direct market access for suppliers-all powered by its proprietary AI framework, Navan Cognition. Geographically, the company operates in United States, United Kingdom and Other countries, of which United States derives maximum revenue.